ATRA — Atara Biotherapeutics Inc · rev $1.1M

Atara Biotherapeutics Inc (ATRA) is a biotechnology company listed on NASDAQ.

Latest reported ATRA revenue for 2026-06-30 was $1.1M. Net income was -$9.0M. ATRA currently screens at market cap $87.1M.

Use this ATRA page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the ATRA quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the ATRA SEC filings page. Lician reads the product cache first so this HTML stays unique to Atara Biotherapeutics Inc even when a live quote feed is slow.

Atara Biotherapeutics Inc latest statements (FY2025)

Latest cached year on this hub. Full ATRA income, balance, and cash tables.

  • Revenue$120.8M
  • Net Income$32.7M
  • Total Assets$20.2M
  • Total Debt$0
  • Free Cash Flow-$50.9M

ATRA recent filings